← back to search

Risa Kagan

Sutter Health · US
Area of research
Endocrinology, Diabetes and Metabolism · Genetics
Research interest
Research interests include Menopause: Health Impacts and Treatments, Estrogen and related hormone effects, Bone health and osteoporosis research, and Bone health and treatments.
h-index
28
citations
3,343
works
82
NIH funding
primary concept
email

Recent publications

Safety of Fezolinetant for Treatment of Moderate to Severe Vasomotor Symptoms Due to Menopause: Pooled Analysis of Three Randomized Phase 3 Studies
Advances in Therapy 2024cited by 10position: firstdoi
Treatment rates and healthcare costs of patients with fragility fracture by site of care: a real-world data analysis
Archives of Osteoporosis 2023cited by 57position: middledoi
Systematic review and network meta-analysis comparing the efficacy of fezolinetant with hormone and nonhormone therapies for treatment of vasomotor symptoms due to menopause
Menopause The Journal of The North American Menopause Society 2023cited by 34position: lastdoi
Practical Treatment Considerations in the Management of Genitourinary Syndrome of Menopause
Drugs & Aging 2019cited by 98position: firstdoi
Management of genitourinary syndrome of menopause in women with or at high risk for breast cancer: consensus recommendations from The North American Menopause Society and The International Society for the Study of Women's Sexual Health
Menopause The Journal of The North American Menopause Society 2018cited by 230position: middledoi
Treatment of moderate to severe dyspareunia with intravaginal prasterone therapy: a review
Climacteric 2018cited by 26position: lastdoi
Safety and benefit considerations for menopausal hormone therapy
Expert Opinion on Drug Safety 2017cited by 43position: middledoi
Goal-Directed Treatment for Osteoporosis: A Progress Report From the ASBMR-NOF Working Group on Goal-Directed Treatment for Osteoporosis
Journal of Bone and Mineral Research 2016cited by 161position: middledoi
Why the product labeling for low-dose vaginal estrogen should be changed
Menopause The Journal of The North American Menopause Society 2014cited by 81position: middledoi
Algorithm and mobile app for menopausal symptom management and hormonal/non-hormonal therapy decision making
Menopause The Journal of The North American Menopause Society 2014cited by 77position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

JoAnn V. Pinkerton · University of Virginia4 papers (2014–2018)Cynthia A. Stuenkel · UC San Diego Health System3 papers (2014–2018)Steven R. Goldstein · New York University3 papers (2014–2018)Andrew M. Kaunitz · University of Florida3 papers (2014–2018)Sheryl A. Kingsberg · Case Western Reserve University2 papers (2014–2018)Sharon J. Parish · Cornell University2 papers (2018–2019)JoAnn E. Manson · The University of Texas Health Science Center at Houston2 papers (2014–2014)Jan L. Shifren · Harvard University2 papers (2014–2014)Peter F. Schnatz · Reading Hospital2 papers (2014–2014)Margery Gass · University Hospital of Bern2 papers (2014–2014)Marla Shapiro · Case Western Reserve University2 papers (2014–2018)Wulf H. Utian · Palo Alto University2 papers (2014–2014) · 2 papers (2023–2024)Suzanne M. Jan de Beur · University of Virginia1 papers (2016–2016)Douglas P. Kiel · Harvard University1 papers (2016–2016)Tami S. Rowen · University of California, San Francisco1 papers (2018–2018)Oscar Patterson‐Lomba · Analysis Group (United States)1 papers (2023–2023)Susan Kellogg‐Spadt · Bryn Mawr College1 papers (2019–2019) · 1 papers (2023–2023)Diane Todd Pace · University of Tennessee at Knoxville1 papers (2014–2014)